355 related articles for article (PubMed ID: 22381062)
1. Synthesis, structure-activity relationship, and pharmacophore modeling studies of pyrazole-3-carbohydrazone derivatives as dipeptidyl peptidase IV inhibitors.
Wu D; Jin F; Lu W; Zhu J; Li C; Wang W; Tang Y; Jiang H; Huang J; Liu G; Li J
Chem Biol Drug Des; 2012 Jun; 79(6):897-906. PubMed ID: 22381062
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, evaluation and molecular docking of thiazolopyrimidine derivatives as dipeptidyl peptidase IV inhibitors.
Sharma M; Gupta M; Singh D; Kumar M; Kaur P
Chem Biol Drug Des; 2012 Dec; 80(6):918-28. PubMed ID: 22943413
[TBL] [Abstract][Full Text] [Related]
3. Discovering novel α-aminoacyl-containing proline derivatives with potent and selective inhibitory activity against dipeptidyl peptidase IV: design, synthesis, biological evaluation, and molecular modeling.
Zhang X; Wang J; Su M; Li Z; Li J; Li J; Liu H
Chem Biol Drug Des; 2012 Dec; 80(6):843-52. PubMed ID: 22726613
[TBL] [Abstract][Full Text] [Related]
4. Identification of dipeptidyl peptidase IV inhibitors: virtual screening, synthesis and biological evaluation.
Xing J; Li Q; Zhang S; Liu H; Zhao L; Cheng H; Zhang Y; Zhou J; Zhang H
Chem Biol Drug Des; 2014 Sep; 84(3):364-77. PubMed ID: 24674599
[TBL] [Abstract][Full Text] [Related]
5. In silico approaches to predict the potential of milk protein-derived peptides as dipeptidyl peptidase IV (DPP-IV) inhibitors.
Nongonierma AB; Mooney C; Shields DC; FitzGerald RJ
Peptides; 2014 Jul; 57():43-51. PubMed ID: 24793774
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel benzyl-substituted (S)-phenylalanine derivatives as potent dipeptidyl peptidase 4 inhibitors.
Liu Y; Si M; Tang L; Shangguan S; Wu H; Li J; Wu P; Ma X; Liu T; Hu Y
Bioorg Med Chem; 2013 Sep; 21(18):5679-87. PubMed ID: 23938053
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, structure-activity relationships, and docking studies of 1-(γ-1,2,3-triazol substituted prolyl)-(S)-3,3-difluoropyrrolidines as a novel series of potent and selective dipeptidyl peptidase-4 inhibitors.
Zhang L; Su M; Li J; Ji X; Wang J; Li Z; Li J; Liu H
Chem Biol Drug Des; 2013 Feb; 81(2):198-207. PubMed ID: 22994702
[TBL] [Abstract][Full Text] [Related]
8. Discovery of new chemotype dipeptidyl peptidase IV inhibitors having (R)-3-amino-3-methyl piperidine as a pharmacophore.
Nishio Y; Kimura H; Tosaki S; Sugaru E; Sakai M; Horiguchi M; Masui Y; Ono M; Nakagawa T; Nakahira H
Bioorg Med Chem Lett; 2010 Dec; 20(24):7246-9. PubMed ID: 21074430
[TBL] [Abstract][Full Text] [Related]
9. Substituted piperidinyl glycinyl 2-cyano-4,5-methano pyrrolidines as potent and stable dipeptidyl peptidase IV inhibitors.
Zhao G; Kwon C; Wang A; Robertson JG; Marcinkeviciene J; Parker RA; Kirby MS; Hamann LG
Bioorg Med Chem Lett; 2013 Mar; 23(6):1622-5. PubMed ID: 23416006
[TBL] [Abstract][Full Text] [Related]
10. Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation.
Meduru H; Wang YT; Tsai JJ; Chen YC
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27304951
[TBL] [Abstract][Full Text] [Related]
11. A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitors.
Lu IL; Tsai KC; Chiang YK; Jiaang WT; Wu SH; Mahindroo N; Chien CH; Lee SJ; Chen X; Chao YS; Wu SY
Eur J Med Chem; 2008 Aug; 43(8):1603-11. PubMed ID: 18207285
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, evaluation and molecular docking of prolyl-fluoropyrrolidine derivatives as dipeptidyl peptidase IV inhibitors.
Sharma M; Gupta M; Singh D; Kumar M; Kaur P
Chem Biol Drug Des; 2013 Aug; 82(2):156-66. PubMed ID: 23581745
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of all eight stereoisomers of DPP-IV inhibitor saxagliptin.
Dong J; Gong Y; Liu J; Chen X; Wen X; Sun H
Bioorg Med Chem; 2014 Feb; 22(4):1383-93. PubMed ID: 24457090
[TBL] [Abstract][Full Text] [Related]
14. Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening.
Al-Masri IM; Mohammad MK; Taha MO
ChemMedChem; 2008 Nov; 3(11):1763-79. PubMed ID: 18989859
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of thiouracil derivatives as dipeptidyl peptidase IV inhibitors.
Sharma M; Singh D; Gupta M
Chem Biol Drug Des; 2013 Feb; 81(2):257-64. PubMed ID: 23039850
[TBL] [Abstract][Full Text] [Related]
16. [Design, synthesis and in vitro activity of glycinamide-bearing compounds as DPP-IV inhibitors].
Han B; Huan Y; Lin ZY; Li P; Shen ZF; Yin DL; Huang HH
Yao Xue Xue Bao; 2010 Nov; 45(11):1379-84. PubMed ID: 21361038
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.
Patel BD; Bhadada SV; Ghate MD
Bioorg Chem; 2017 Jun; 72():345-358. PubMed ID: 28302310
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, biological evaluation, and docking studies of (s)-phenylalanine derivatives with a 2-cyanopyrrolidine moiety as potent dipeptidyl peptidase 4 inhibitors.
Liu Y; Wu Y; Wu H; Tang L; Wu P; Liu T; Hu Y
Chem Biol Drug Des; 2013 Aug; 82(2):140-6. PubMed ID: 23530834
[TBL] [Abstract][Full Text] [Related]
19. Discovery of potent, selective, and orally bioavailable quinoline-based dipeptidyl peptidase IV inhibitors targeting Lys554.
Maezaki H; Banno Y; Miyamoto Y; Moritoh Y; Asakawa T; Kataoka O; Takeuchi K; Suzuki N; Ikedo K; Kosaka T; Sasaki M; Tsubotani S; Tani A; Funami M; Yamamoto Y; Tawada M; Aertgeerts K; Yano J; Oi S
Bioorg Med Chem; 2011 Aug; 19(15):4482-98. PubMed ID: 21741847
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of xanthine derivatives on dipeptidyl peptidase 4.
Lin K; Cai Z; Wang F; Zhang W; Zhou W
Chem Pharm Bull (Tokyo); 2013; 61(4):477-82. PubMed ID: 23358258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]